Back to VA VANGUARD CAPITAL MANAGEMENT LLC

KLRSKLRS
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in KALARIS THERAPEUTICS INC

Yes. Vanguard Capital Management holds 398,712 shares of KLRS (Kalaris Therapeutics), worth $1.6M, as of its Q2 2026 13F filing. It increased the position by 143,364 shares (+56.1%) from Q1 2026. Vanguard Capital Management has held KLRS in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$1.6M

Current Shares

398,712

Total Value Change

+$149,400

Total Shares Change

+143,364

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
398,712
+56.1%
$1.6M0.0%$4.07
25
2026-Q1
First report
255,348
-
$1.5M0.0%$9.42
0

Other major holders of KLRS: RTW INVESTMENTS, LP, Alyeska Investment Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used